Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association
Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association
复制标题
DOI：
10.1161/hyp.0000000000000203
复制
发表时间：
2022-01-01
期刊：
影响因子：
8.3
通讯作者：
Hyman, David J.
中科院分区：
文献类型：
--
作者：
Choudhry, Niteesh K.;Kronish, Ian M.;Hyman, David J.
对高血压的广泛治疗和由此产生的血压改善是心脏病和中风的年龄特异性急剧下降的主要原因。尽管取得了这些进展，但在既定的公共卫生目标和实现的血压控制率之间仍然存在持续的差距。许多因素可能是造成人群高血压控制目标与当前观察到的控制水平之间存在差距的重要因素。其中之一是病人坚持规定治疗的程度。本科学声明的目的是总结药物不依从性对全国血压控制不良患病率的贡献的当前知识状态，测量药物依从性的方法及其相关挑战，抗高血压药物不依从性的风险因素，以及在个人和卫生系统水平提高抗高血压药物依从性的策略。
The widespread treatment of hypertension and resultant improvement in blood pressure have been major contributors to the dramatic age-specific decline in heart disease and stroke. Despite this progress, a persistent gap remains between stated public health targets and achieved blood pressure control rates. Many factors may be important contributors to the gap between population hypertension control goals and currently observed control levels. Among them is the extent to which patients adhere to prescribed treatment. The goal of this scientific statement is to summarize the current state of knowledge of the contribution of medication nonadherence to the national prevalence of poor blood pressure control, methods for measuring medication adherence and their associated challenges, risk factors for antihypertensive medication nonadherence, and strategies for improving adherence to antihypertensive medications at both the individual and health system levels.